ES2183089T3 - Forma posologica de gelatina blanda multifase. - Google Patents

Forma posologica de gelatina blanda multifase.

Info

Publication number
ES2183089T3
ES2183089T3 ES97304607T ES97304607T ES2183089T3 ES 2183089 T3 ES2183089 T3 ES 2183089T3 ES 97304607 T ES97304607 T ES 97304607T ES 97304607 T ES97304607 T ES 97304607T ES 2183089 T3 ES2183089 T3 ES 2183089T3
Authority
ES
Spain
Prior art keywords
posological
multiphase
gelatine
white
white gelatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97304607T
Other languages
English (en)
Inventor
Michael R Hoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Application granted granted Critical
Publication of ES2183089T3 publication Critical patent/ES2183089T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE UNA FORMA DE DOSIFICACION QUE CONTIENE UNA CAPSULA COMUN DE MATERIAL POLIMERICO. LA CAPSULA CONTIENE MULTIPLES FASES DE MATERIALES DE RELLENO SEMISOLIDOS QUE CONTIENEN INGREDIENTES ACTIVOS.
ES97304607T 1996-06-28 1997-06-27 Forma posologica de gelatina blanda multifase. Expired - Lifetime ES2183089T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (1)

Publication Number Publication Date
ES2183089T3 true ES2183089T3 (es) 2003-03-16

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97304607T Expired - Lifetime ES2183089T3 (es) 1996-06-28 1997-06-27 Forma posologica de gelatina blanda multifase.

Country Status (24)

Country Link
US (1) US6024980A (es)
EP (1) EP0815855B1 (es)
JP (1) JPH10182437A (es)
KR (1) KR980000438A (es)
CN (1) CN1172642A (es)
AR (1) AR007648A1 (es)
AT (1) ATE223707T1 (es)
AU (1) AU2620197A (es)
BR (1) BR9703771A (es)
CO (1) CO4900025A1 (es)
CZ (1) CZ205697A3 (es)
DE (1) DE69715319T2 (es)
DK (1) DK0815855T3 (es)
ES (1) ES2183089T3 (es)
HU (1) HUP9701113A2 (es)
ID (1) ID17794A (es)
IL (1) IL121145A0 (es)
NO (1) NO972963L (es)
NZ (1) NZ328182A (es)
PL (1) PL320815A1 (es)
PT (1) PT815855E (es)
SG (1) SG54525A1 (es)
TN (1) TNSN97111A1 (es)
ZA (1) ZA975767B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12527745B2 (en) 2018-02-26 2026-01-20 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
EP1163901B1 (en) * 1999-02-26 2008-09-10 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
AU2002330285A1 (en) * 2001-09-18 2003-04-01 The North West University Triclosan dosage form
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20050020613A1 (en) * 2002-09-20 2005-01-27 Alpharma, Inc. Sustained release opioid formulations and method of use
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
EP3064064A1 (en) * 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
MX2014011139A (es) * 2012-04-13 2015-07-17 Banner Life Sciences Llc Cápsulas elásticas blandas que contienen comprimidos y rellenos líquidos o semisólidos y métodos para su fabricacion.
CN104968333B (zh) 2012-11-30 2018-07-10 阿库拉制药公司 活性药物成分的自调节释放
BR112015022946A8 (pt) * 2013-03-15 2022-11-29 Warner Chilcott Co Llc Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6510628B2 (ja) 2014-03-26 2019-05-15 サン・ファーマ・アドバンスト・リサーチ・カンパニー・リミテッド 乱用防止即時放出性被覆リザーバ固体剤形
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US12582637B2 (en) * 2018-08-31 2026-03-24 Arctic Therapeutics Hf Topical formulation for intradermal application and uses thereof
WO2026127819A1 (en) * 2024-12-13 2026-06-18 Novex Science Pte Limited Transient oil-in-simethicone emulsion

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
EP0211079A4 (en) * 1985-01-31 1988-02-15 Fujisawa Pharmaceutical Co Soft multi-chamber capsule and method of and apparatus for manufacturing same.
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
AU682192B2 (en) * 1993-06-30 1997-09-25 Fujisawa Pharmaceutical Co., Ltd. Encapsulated medicine
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12527745B2 (en) 2018-02-26 2026-01-20 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide

Also Published As

Publication number Publication date
NO972963D0 (no) 1997-06-25
CO4900025A1 (es) 2000-03-27
AR007648A1 (es) 1999-11-10
CZ205697A3 (cs) 1998-01-14
EP0815855A1 (en) 1998-01-07
SG54525A1 (en) 1998-11-16
DE69715319D1 (de) 2002-10-17
AU2620197A (en) 1998-01-15
HU9701113D0 (en) 1997-08-28
IL121145A0 (en) 1997-11-20
ZA975767B (en) 1998-12-28
CN1172642A (zh) 1998-02-11
NZ328182A (en) 1998-11-25
TNSN97111A1 (fr) 2005-03-15
US6024980A (en) 2000-02-15
EP0815855B1 (en) 2002-09-11
BR9703771A (pt) 1998-09-01
NO972963L (no) 1997-12-29
ATE223707T1 (de) 2002-09-15
PT815855E (pt) 2003-01-31
DK0815855T3 (da) 2003-01-06
HUP9701113A2 (hu) 1998-08-28
MX9704846A (es) 1998-07-31
KR980000438A (ko) 1998-03-30
DE69715319T2 (de) 2003-01-23
PL320815A1 (en) 1998-01-05
ID17794A (id) 1998-01-29
JPH10182437A (ja) 1998-07-07

Similar Documents

Publication Publication Date Title
ES2066340T3 (es) Productos perfumados para la higiene de la axila.
NO972963L (no) Flerfaset mykgelatin-doseringsform
ES2083353T3 (es) Sistema infectivo de liberacion de farmacos.
ES530270A0 (es) Una forma de dosificacion unitaria farmaceutica
AR243075A1 (es) Composicion perfumante de fase acuosa continua que tiene una concentracion elevada de perfume.
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
ES2120516T3 (es) Preparacion de composiciones farmaceuticas que contienen una calcitonina.
BR9800871A (pt) Processo para a preparação de formas medicamentosas combinadas sólidas, e, forma medicamentosa combinada sólida.
AR005152A1 (es) Amidas tricíclicas útiles para la inhibición de la función de la proteina-g, sus sales , una composición farmacéutica que las contienen y el uso de las mismas para la fabricación de un medicamento para el tratamiento de enfermedades proliferativas
ES2129806T3 (es) Composiciones liquidas orales que contienen resinato de paroxetina.
ES2053962T3 (es) Dentrificos conteniendo amino alquil siliconas.
AR001714A1 (es) Una composición de barra detergente estructurada con polialquileno y que comprende una amida organica y un método para preparar dicha composición
FI905684A0 (fi) Farmaceutisk doseringsform foer utdelning av medicin aot fiskar.
NO973014D0 (no) Fyllmateriale for farmasöytisk mykgelatin-doseringsform
ATE40853T1 (de) Weichkapsel.
CY1105465T1 (el) Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα
NO179091C (no) Stabil forpakket jodoforlösning omfattende polyetylenvegget beholder
FR2689762B1 (fr) Compositions cosmetiques contenant une vitamine e polyethoxylee.
DE59506611D1 (de) Befüllung von pharmazeutischen mehrkammerverpackungen
BR9703792A (pt) Material de enchimento para forma de dosagem farmacéutica de gelatina macia contendo um anti flatuléncia
NO996492D0 (no) Opploesningsdoseringsformer av sertralin innkapslet i gelatin
IT1298732B1 (it) Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
MX9205852A (es) Composiciones farmaceuticas que contienen una calcitonina
FR2649680B1 (fr) Emballage rigide pour un objet allonge, notamment une ampoule pharmaceutique
DE60106280D1 (de) Verabreichungskapseln